US appeals court says Watson did not infringe Cephalon patents

NEW YORK Thu Feb 14, 2013 12:29pm EST

NEW YORK Feb 14 (Reuters) - A U.S. appeals court reversed part of a ruling in favor of Watson Pharamaceutials over Cephalon in patent lawsuit over the cancer drug Fendora.

The U.S. Court of Appeals for the Federal Circuit upheld, however, the lower court's ruling that Watson did not infringe Cephalon's patents.

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.